Anesthetic considerations in Sheldon-Hall syndrome.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Anderson TA; Kasser JR; Holzman RS
  • Source:
    Paediatric anaesthesia [Paediatr Anaesth] 2014 May; Vol. 24 (5), pp. 538-40.
  • Publication Type:
    Case Reports; Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Arnette-Blackwell Country of Publication: France NLM ID: 9206575 Publication Model: Print Cited Medium: Internet ISSN: 1460-9592 (Electronic) Linking ISSN: 11555645 NLM ISO Abbreviation: Paediatr Anaesth Subsets: MEDLINE
    • Publication Information:
      Original Publication: Paris, France : Arnette-Blackwell, c1991-
    • Subject Terms:
    • Abstract:
      Arthrogryposis is characterized by multiple, nonprogressive joint contractures which may be caused by maternal disorders such as oligohydramnios as well as fetal akinesia resulting from primary disorders of muscle, connective tissue, or neurologic tissue. Its prevalence is about 1 : 3000. Distal arthrogryposis (DA) is a heterogenous group of genetic disorders with a characteristic flexion of the joints of the hands and feet divided into different types with additional features. Sheldon-Hall Syndrome (SHS), also known as distal arthrogryposis type 2A (DA2A), has some nonorthopedic features of specific importance to anesthetic care.
    • Accession Number:
      0 (Androstanols)
      0 (Anesthetics, Intravenous)
      0 (Neuromuscular Nondepolarizing Agents)
      E5B8ND5IPE (Methohexital)
      UF599785JZ (Fentanyl)
      WRE554RFEZ (Rocuronium)
    • Subject Terms:
      Distal arthrogryposis type 2B
    • Publication Date:
      Date Created: 20140516 Date Completed: 20141215 Latest Revision: 20190923
    • Publication Date:
      20240829
    • Accession Number:
      10.1111/pan.12303
    • Accession Number:
      24829975